Mount Sinai Logo

Howard Fillit

  • CLINICAL PROFESSOR Geriatrics and Palliative Medicine
  • CLINICAL PROFESSOR Medicine
  • CLINICAL PROFESSOR Neuroscience
Print ProfilePrint Profile

Certifications

  • Geriatric Medicine

  • American Board of Internal Medicine

Education

  • MD, S.U.N.Y. Upstate Medical University

  • BA, Cornell University
    neurobiology

  • Residency, Internal Medicine
    Beth Israel Medical Center

  • Fellowship, Immunology
    Rockefeller University

  • Fellowship, Nephrology
    Society of the New York Hospital

Biography

    Howard Fillit, MD is a board certified geriatrician and a neuroscientist. He is the founding Executive Director of the Institute for the Study of Aging, an Estée Lauder family foundation, and the Alzheimer’s Drug Discovery Foundation, organizations with a common mission of accelerating drug discovery for Alzheimer’s disease through venture philanthropy. Dr. Fillit has had a distinguished academic medicine career at The Rockefeller University and The Mount Sinai School of Medicine where he is currently a clinical professor of geriatrics, medicine and neuroscience. He is the author or co-author of more than 300 scientific and clinical publications, and is the senior editor of the leading international Textbook of Geriatric Medicine and Gerontology. Dr. Fillit has received several awards and honors including the Rita Hayworth Award for Lifetime Achievement from the Alzheimer’s Association. Throughout his career, he has maintained a limited private practice in consultative geriatric medicine with a focus on Alzheimer’s disease and related dementias.

Publications

McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan JM, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Y. Dependence as a unifying construct in defining Alzheimer's disease severity. Alzheimer's & dementia : the journal of the Alzheimer's Association 2010 Nov; 6(6).

Shineman DW, Salthouse TA, Launer LJ, Hof PR, Bartzokis G, Kleiman R, Luine V, Buccafusco JJ, Small GW, Aisen PS, Lowe DA, Fillit HM. Therapeutics for cognitive aging. Annals of the New York Academy of Sciences 2010 Apr; 1191 Suppl 1.

Shineman DW, Fillit HM. A multi-targeted approach for a complex multifaceted disease. Current Alzheimer research 2009 Oct; 6(5).

Shineman DW, Fillit HM. Novel strategies for the prevention of dementia from Alzheimer's disease. Dialogues in clinical neuroscience 2009; 11(2).

Fillit H, Nash DT, Shineman D. Commentary on . Alzheimer's & dementia : the journal of the Alzheimer's Association 2009 Mar; 5(2).

Hauber AB, Johnson FR, Fillit H, Mohamed AF, Leibman C, Arrighi HM, Grundman M, Townsend RJ. Older Americans' risk-benefit preferences for modifying the course of Alzheimer disease. Alzheimer disease and associated disorders; 23(1).

Fillit H, Nash DT, Rundek T, Zuckerman A. Cardiovascular risk factors and dementia. The American journal of geriatric pharmacotherapy 2008 Jun; 6(2).

Johnson KC, Margolis KL, Espeland MA, Colenda CC, Fillit H, Manson JE, Masaki KH, Mouton CP, Prineas R, Robinson JG, Wassertheil-Smoller S. A prospective study of the effect of hypertension and baseline blood pressure on cognitive decline and dementia in postmenopausal women: the Women's Health Initiative Memory Study. Journal of the American Geriatrics Society 2008 Aug; 56(8).

McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan JM, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Y. Dependence as a unifying construct in defining Alzheimer's disease severity. Alzheimer's & dementia : the journal of the Alzheimer's Association 2010 Nov; 6(6).

Fillit H, Butler RN. The frailty identity crisis. Journal of the American Geriatrics Society 2009 Feb; 57(2).

Refolo LM, Fillit HM. Partnerships between philanthropy, government and industry are needed to advance drug discovery for neurodegenerative diseases. Current Alzheimer research 2006 Jul; 3(3).

Studenski S, Carlson MC, Fillit H, Greenough WT, Kramer A, Rebok GW. From bedside to bench: does mental and physical activity promote cognitive vitality in late life?. Science of aging knowledge environment : SAGE KE 2006 May; 2006(10).

Ashford JW, Borson S, O'Hara R, Dash P, Frank L, Robert P, Shankle WR, Tierney MC, Brodaty H, Schmitt FA, Kraemer HC, Buschke H, Fillit H. Should older adults be screened for dementia? It is important to screen for evidence of dementia!. Alzheimer's & dementia : the journal of the Alzheimer's Association 2007 Apr; 3(2).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr.Fillit is not currently required to report Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

121 East 60th Street,
4th Floor
New York, NY 10022

Tel: 212-758-4633
Howard Fillit, M.D.

121 East 60th Street
4th Floor
New York, NY 10022

Tel: 212-901-8000
Fax: 212-901-8010
Get Directions
Payment Methods
  • Master Card
  • Visa
  • American Express
  • Discover
  • Personal Check
  • Cash
  • Other
  • Credit Card (Other)